Sage Rhino Capital’s ICU Medical ICUI Stock Holding History

Sage Rhino Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,180	Closed	-$215K	–	282
2024 Q3	$215K	Buy	+1,180	New	+$175K	0.05%	237

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sage Rhino Capital's ICUI Position: Q4 2024 in Review

Sage Rhino Capital sold out of ICU Medical (ICUI) in Q4 2024, closing a stake of 1,180 shares — an estimated $215K sold.

Sage Rhino Capital first reported a position in ICUI in Q3 2024 and held it in 1 quarter. The position peaked at $215K in Q3 2024. 286 funds tracked by Wall St. Rank hold ICUI as of Q4 2024.

Sage Rhino Capital reported no remaining ICU Medical position as of Q4 2024 after selling out during the quarter.
Sage Rhino Capital sold 1,180 ICU Medical shares in Q4 2024, an estimated $215K.
Sage Rhino Capital first reported a position in ICU Medical in Q3 2024 and held it in 1 quarter.
Sage Rhino Capital's ICU Medical position peaked at $215K in Q3 2024.
286 funds tracked by Wall St. Rank held ICU Medical as of Q4 2024.

Based on Sage Rhino Capital's 13F filing for Q4 2024, filed 6 Feb 2025.